Activating an Adaptive Immune Response with a Telomerase-Mediated Telomere Targeting Therapeutic in Hepatocellular Carcinoma

Ilgen Mender(The University of Texas Southwestern Medical Center), Jerry W. Shay(The University of Texas Southwestern Medical Center)
Molecular Cancer Therapeutics
April 18, 2023
Cited by 14


Related Papers